Research & Development

Academic Report

【Publication of a paper】Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy

Sysmex is pleased to announce that our research paper has been published in the journal of Alzheimer's Research & Therapy.

Title: Fully automated and highly specific plasma β-amyloid immunoassays predict
β-amyloid status defined by amyloid positron emission tomography with high accuracy
 
Presented by:  Kazuto Yamashita1), Masahiro Miura1), Shunsuke Watanabe1), Kengo Ishiki1),
Yuji Arimatsu2), Junko Kawahira3), Toshiko Kubo3), Katsutaka Sasaki4),
Takayuki Arai4), Kei Hagino2), Yasuhiro Irino1), Kota Nagai5), David Verbel6),
Akihiko Koyama7), Shobha Dhadda8), Hayato Niiro9), Shigeki Iwanaga1),
Toshiyuki Sato1), Tomokazu Yoshida10), Atsushi Iwata11)
1) Central Research Laboratories, Sysmex Corporation, Kobe, Japan
2) Business Incubation Division, Sysmex Corporation, Kobe, Japan
3) Reagent Engineering Division, Sysmex Corporation, Kobe, Japan
4) Sysmex R&D Center Americas, Inc., Mundelein, Illinois, USA
5) Japan and Asia Clinical Development Department, Eisai Co., Ltd., Japan
6) Biostatistics, Eisai Inc., Nutley, NJ, USA
7) Translational Science, Eisai Inc., Nutley, NJ, USA
8) Biostatistics and Clinical Development Operations, Eisai Inc., Nutley, NJ, USA
9) Medical Affairs Division, Sysmex Corporation, Kobe, Japan
10) Sysmex Corporation, Kobe, Japan
11) Department of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of
      gerontology, Tokyo, Japan

Journal: Alzheimer's Research & Therapy 14, Article number: 86 (2022)
 
Link: https://alzres.biomedcentral.com/articles/10.1186/s13195-022-01029-0
 

 

 
  • Information contained in the academic report is current as of the date of the announcement,
    but may be subject to change without prior notice.

Back to "Academic Report"